GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » ROCE %

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) ROCE % : -411.43% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NP Life Sciences Health Industry Group's annualized ROCE % for the quarter that ended in Dec. 2023 was -411.43%.


NP Life Sciences Health Industry Group ROCE % Historical Data

The historical data trend for NP Life Sciences Health Industry Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group ROCE % Chart

NP Life Sciences Health Industry Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -101.87 -77.29 -92.96 -65.52 -3.39

NP Life Sciences Health Industry Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 591.30 20.00 652.87 -302.04 -411.43

NP Life Sciences Health Industry Group ROCE % Calculation

NP Life Sciences Health Industry Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.001/( ( (0.128 - 0.108) + (0.077 - 0.038) )/ 2 )
=-0.001/( (0.02+0.039)/ 2 )
=-0.001/0.0295
=-3.39 %

NP Life Sciences Health Industry Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-0.144/( ( (0.095 - 0.064) + (0.077 - 0.038) )/ 2 )
=-0.144/( ( 0.031 + 0.039 )/ 2 )
=-0.144/0.035
=-411.43 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NP Life Sciences Health Industry Group  (OTCPK:NPLS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


NP Life Sciences Health Industry Group ROCE % Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Traded in Other Exchanges
N/A
Address
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506
NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.
Executives
Guidong Wang director, 10 percent owner, officer: Chairman, CEO. Pres, Treas 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg director 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang director, officer: CEO, President and Treasurer 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu director, 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines